Parallax Health Sciences Inc. (PRLX) Financials No
Post# of 250675
Posted On: 11/17/2014 1:37:17 AM
Parallax Health Sciences Inc. (PRLX) Financials Nov 11, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Parallax Health Sciences Inc.
Fiscal year is January-December. All values USD millions. 2008 2009 2010 2012 2013 5-year trend
Sales/Revenue 0 0 20,397 0 0
Cost of Goods Sold (COGS) incl. D&A 0 0 80,581 18,550 12,232
COGS excluding D&A 0 0 79,928 0 0
Depreciation & Amortization Expense 0 0 653 18,550 12,232
Depreciation - - 653 16,883 10,566
Amortization of Intangibles 0 0 0 1,667 1,666
Gross Income 0 0 (60,184) (18,550) (12,232)
2008 2009 2010 2012 2013 5-year trend
SG&A Expense 43,500 4.16M 14,431 482,568 473,403
Research & Development 0 0 0 0 -
Other SG&A 43,500 4.16M 14,431 482,568 473,403
Other Operating Expense 62,067 155,393 1M 0 0
Unusual Expense 5.98M 609,718 3.29M 0 0
EBIT after Unusual Expense (5.98M) (609,718) (3.29M) 0 0
Non Operating Income/Expense 0 0 0 0 1,695
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 0 167,094 759,387 53,550 20,554
Gross Interest Expense 0 167,094 759,387 53,550 20,554
Interest Capitalized 0 0 0 0 0
Pretax Income (6.08M) (5.09M) (5.13M) (554,668) (504,494)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (6.08M) (5.09M) (5.13M) (554,668) (504,494)
Minority Interest Expense 0 0 0 0 0
Net Income (6.08M) (5.09M) (5.13M) (554,668) (504,494)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (6.08M) (5.09M) (5.13M) (554,668) (504,494)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (6.08M) (5.09M) (5.13M) (554,668) (504,494)
EPS (Basic) (9.00) (8.00) (0.12) (0.01) ()
Basic Shares Outstanding 653,449 670,346 41.1M 107.72M 150.7M
EPS (Diluted) (9.00) (8.00) (0.12) (0.01) ()
Diluted Shares Outstanding 653,449 670,346 41.1M 107.72M 150.7M
EBITDA (105,567) (4.32M) (1.08M) (482,568) (473,403)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Parallax Health Sciences Inc.
Fiscal year is January-December. All values USD millions. 2008 2009 2010 2012 2013 5-year trend
Sales/Revenue 0 0 20,397 0 0
Cost of Goods Sold (COGS) incl. D&A 0 0 80,581 18,550 12,232
COGS excluding D&A 0 0 79,928 0 0
Depreciation & Amortization Expense 0 0 653 18,550 12,232
Depreciation - - 653 16,883 10,566
Amortization of Intangibles 0 0 0 1,667 1,666
Gross Income 0 0 (60,184) (18,550) (12,232)
2008 2009 2010 2012 2013 5-year trend
SG&A Expense 43,500 4.16M 14,431 482,568 473,403
Research & Development 0 0 0 0 -
Other SG&A 43,500 4.16M 14,431 482,568 473,403
Other Operating Expense 62,067 155,393 1M 0 0
Unusual Expense 5.98M 609,718 3.29M 0 0
EBIT after Unusual Expense (5.98M) (609,718) (3.29M) 0 0
Non Operating Income/Expense 0 0 0 0 1,695
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 0 167,094 759,387 53,550 20,554
Gross Interest Expense 0 167,094 759,387 53,550 20,554
Interest Capitalized 0 0 0 0 0
Pretax Income (6.08M) (5.09M) (5.13M) (554,668) (504,494)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (6.08M) (5.09M) (5.13M) (554,668) (504,494)
Minority Interest Expense 0 0 0 0 0
Net Income (6.08M) (5.09M) (5.13M) (554,668) (504,494)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (6.08M) (5.09M) (5.13M) (554,668) (504,494)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (6.08M) (5.09M) (5.13M) (554,668) (504,494)
EPS (Basic) (9.00) (8.00) (0.12) (0.01) ()
Basic Shares Outstanding 653,449 670,346 41.1M 107.72M 150.7M
EPS (Diluted) (9.00) (8.00) (0.12) (0.01) ()
Diluted Shares Outstanding 653,449 670,346 41.1M 107.72M 150.7M
EBITDA (105,567) (4.32M) (1.08M) (482,568) (473,403)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)